Timeline
Moderna
US mRNA vaccine company; running Phase 3 H5N1 trial and new CEPI-backed Bundibugyo Phase 1 programme.
6 of 6 entries (6 events, 0 interactions)
Filters
#7 8 Jun
Mentioned in: CEPI funds a fourth Ebola vaccine
Pandemics and Biosecurity#6 1 Jun
Received $50m CEPI commitment for Bundibugyo mRNA candidate through Phase 1
Pandemics and Biosecurity: $112m for vaccines, none for the wards#4 21 May
CEPI rescues Moderna H5N1 vaccine trial
Pandemics and Biosecurity#3 17 May
Mentioned in: No vaccine, no treatment, no MCM
Pandemics and Biosecurity#2 12 May
Mentioned in: Idaho dairy H5N1: 1 to 59 herds in twelve days
Pandemics and Biosecurity#1 22 Apr